The Multivitamin Verdict: 3-Year Study Settles the Healthy Aging Debate

On Tuesday, July 29, 2026, the multi-year debate over whether daily multivitamins actually do anything for healthy adults finally got a definitive answer. According to a major new study presented at NUTRITION 2026 and published in Nature Medicine, older adults who took a daily multivitamin for three years demonstrated significantly better functional health compared to those taking a placebo.

The findings are a landmark in longevity research, providing hard, long-term data showing that a simple daily pill can help preserve physical function, mobility, and independence in aging populations. This new data builds on a growing body of evidence from the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) and related trials, which have repeatedly shown that targeted daily nutrition can slow both cognitive and biological aging in measurable, clinically meaningful ways.

Settling the Supplementation Debate

For decades, the medical establishment has been deeply skeptical of daily multivitamins. Landmark cohort studies, including a massive 2024 NIH analysis of nearly 400,000 adults, previously found that multivitamin use did not reduce mortality risk. Physicians largely dismissed the daily pill as creating nothing more than "expensive urine."

However, clinical researchers have maintained that looking only at mortality—whether a supplement prevents death—misses a far more critical metric for older adults: how well they live. The question driving the recent COSMOS-affiliated research was not whether a multivitamin helps you live forever, but whether it helps you maintain the ability to carry groceries, climb stairs, and live independently.

Presented at NUTRITION 2026, the American Society for Nutrition's flagship annual meeting held July 27-29 in Boston, this latest functional health analysis delivers a clear affirmative. Researchers tracked older adults for three years and found that those randomized to take a daily multivitamin—specifically Centrum Silver in the COSMOS trial—maintained significantly better measures of functional health compared to those who received a placebo. The participants' daily function and physical capabilities were measurably preserved.

The Metrics: Measuring Independence

To understand the significance of the July 29 data, you have to look at how functional health is measured. Researchers rely on the 36-Item Short Form Health Survey (SF-36), a standardized questionnaire that evaluates physical functioning, bodily pain, and role limitations due to physical health problems. It asks adults to rate their ability to perform tasks ranging from vigorous activities (like running) to basic self-care.

Over the three-year study period, the functional health scores of the placebo group predictably declined, tracking with standard age-related physical degradation. But the multivitamin group maintained a measurably higher baseline of physical capability. The research team noted that the supplement's effect was modest but clinically meaningful—preserving the exact type of functional independence that dictates whether an older adult can age in place at home or requires assisted living.

“For older adults, these findings suggest that a daily multivitamin could be a helpful, low-risk addition to a healthy lifestyle to support functional health,” the study authors emphasized in their conference presentation.

Biological Aging: The Epigenetic Evidence

While the July 2026 functional health data is new, it strongly corroborates a major epigenetic bombshell published earlier this year. In March 2026, researchers published findings in Nature Medicine showing that taking a daily multivitamin for two years significantly slowed biological aging in older adults.

Led by investigators at Mass General Brigham and the Harvard T.H. Chan School of Public Health, the COSMOS epigenetic study analyzed DNA methylation using five validated "epigenetic clocks." These clocks measure specific chemical tags on DNA to determine how old a person's cells appear, regardless of their chronological age. Compared to the placebo group, participants taking the daily multivitamin showed slowing across all five clocks, statistically decelerating their biological aging by approximately four months over a two-year period.

Crucially, the anti-aging effect was not uniform. The researchers found that the supplement's impact was greater in people who were already biologically older than their chronological years—specifically those carrying a higher burden of chronic disease or exhibiting advanced physiological decline. For adults who were aging poorly, the multivitamin intervened the hardest.

Cognitive Preservation: A Fleet of Defense

Preserving physical mobility and slowing cellular aging is vital, but functional health also relies heavily on cognitive preservation. The July 2026 functional health findings add a third pillar to what is now a comprehensive, data-backed defense of daily multivitamin supplementation in older adults.

A landmark 2023 study published in the American Journal of Clinical Nutrition demonstrated that daily multivitamin supplementation significantly improves memory in older adults. Specifically, the COSMOS cognitive substudies estimated that three years of multivitamin supplementation translated to a roughly 60% slowing of cognitive decline—equivalent to about 1.8 years of brain aging prevented. The meta-analysis confirmed significant benefits for both global cognition and episodic memory, establishing the pill as a formidable defense against age-related memory loss.

When viewed together—the newly minted functional health data of July 2026, the epigenetic aging data of March 2026, and the cognitive preservation data of 2023—the verdict on daily multivitamins for older adults is unequivocally positive.

Putting the Findings Into Practice

The data is clear, but execution matters. Not all multivitamins are created equal, and the results of the COSMOS trial specifically apply to a standard, high-quality daily multivitamin (the trial utilized Centrum Silver, a widely available commercial brand). Furthermore, researchers are quick to point out that a multivitamin is a supplement, not a substitute. Multivitamins are most effective as a low-cost insurance policy against nutritional gaps, not as a replacement for a diet rich in whole foods, fiber, and lean proteins.

The demographic that stands to benefit most is adults over 60, particularly those who eat very little, have poor dietary variety, or are managing chronic conditions that put them at a higher risk of accelerated biological aging. The COSMOS trial's participant pool—numbering over 21,000 U.S. adults—gives these findings robust, real-world applicability.

As the research moves forward, scientists are now looking at how specific genetic profiles and baseline nutritional deficiencies dictate who responds best to daily supplementation. For now, the old medical adage that multivitamins are a waste of money has been scientifically retired. For adults looking to preserve their mobility, protect their brain, and slow their biological clock, the cheapest pill in the pharmacy aisle just became the most evidence-backed.